Figure 1.

GNA13 is overexpressed in CRC and its overexpression in associated with poor prognosis. A, The mRNA level of GNA13 in CRC tissues (Tumor) and paired normal tissues (Normal) was analyzed by real‐time RT‐PCR. B, GNA13 protein level in CRC tissues and paired normal tissues was assessed by Western blotting. C, Immunohistochemistry of GNA13 in nontumor and primary CRC tissue arrays containing 74 cases. D, Relative mRNA expression of Six1 in HCC samples from patients with disease recurrence (n = 22) or without disease recurrence (n = 23). E, Relative mRNA expression of Six1 in HCC samples from patients with metastasis (n = 19) or without metastasis (n = 22). F, Kaplan‐Meier analysis of overall survival for patients with CRC. The analyses were conducted based on the immunohistochemistry of GNA13 and the survival information provided by the supplier